Table 1.
Study characteristics.
Study | Country | Year of publication | Population | Number of patient | Number of polyp | Mean age (year) | Male sex | Size of polyp (Mean) | Type of polyp | Location of polyp | Comparision | Concentration of epinephrine solution | Polypectomy method | Outcome variable | Pathology | Post polypectomy bleeding (%) | Anticoaulant used or coagulopathy | Blood tranfusion | Modified Jadad score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lee SH. | South korea | 2007 | Multicenter | 486 | 561 | Epinephrine group: 51.6 ± 11.4, Controlled group: 56.8 ± 11.3 | 379 | Epinephrine group: 14.5 ± 5.7 mm, Controlled group:15.0 ± 6.8 mm. | Pedunculated: 128 Semipeduncul ated: 200 Sessile: 150 Superficial elevated type: 83 | Right colon (include transverse colon):99 Left colon:257 Both: 130 | Epinephrine versus Controlled (normal saline solution) | 0.01% (Total volume 2–25 ml) | Bipolar cauterization, blended current (30–40 Watts) | -Early bleeding (within 12 h) - Late bleeding (12 h.-30 days) | Nonneoplastic: 51 Dysplasia:362 High grade Dysplasia:95 Cancer: 53 | 8% | Excluded | – | 9 |
Hsieh Yh. | Taiwan | 2001 | Single center | 122 | 151 | Epinephrine group 62.9 (59.8–62.1), Controlled group: 64.9 (62.1–67.8) | 80 | Epinephrine group: 8 (8–13) mm., Controlled group: 8 (8–11) mm. | Sessile | Ascending: 10 Transverse: 4 Descending:7 Sigmoid: 50 Rectum 16 | Epinephrine versus Controlled | 0.01% (Total volume 2–10 ml) | Coagulation current (25–30 Watts) | -Early bleeding (within 24 h) -Late bleeding (>24 h.-30 days) -Perforation -Mortality | Nonneoplastic: 12 Tubular: 59 Tubulovillus:13 Villus: 2 Carcinoid: 2 | 6.0% | Excluded | 2 | 6 |
Dobrowolski S. | Poland | 2004 | Single center | 69 | 100 | 64.6 ± 10.5 | 44 | Epinephrine group: 16.3 ± 5.4 mm, Controlled group:16.1 ± 5.9 mm. | Pedunculated: 80 Sessile: 20 | Ascending: 6 Transverse: 10 Descending: 13 Sigmoid: 51 Rectum 20 | Epinephrine versus Controlled | 0.01% (Total volume 2–10 ml) | Endocut, effect 3 (output limit 120 W) and Soft coagulation (output limit 60 W) | -Early bleeding (within 24 h) -Late bleeding (>24 h.-30 days) | Nonneoplastic: 6 Tubular: 23 Tubulovillus:51 Adenocarcinim a: 20 | 9% | Excluded | 2 | 7 |
Paspatis GA. | Greece | 2006 | Multicenter | 159 | 159 | Epinephrine group: 64.5 ± 11, Epinephrine + snare group: 61.7 ± 13.8 | 84 | Epinephrine group: 26.3 ± 8.1 mm, Epinephrine + snare group: 27.1 ± 8.9 mm. | Pedunculated | Right colon: 13 Left colon:130 Rectum: 16 | Epinephrine versus Epinephrine and Detachable snare | 0.01% (Total volume 2–3 ml) | Endocut mode (72 W) | -Early bleeding (within 24 h) -Late bleeding (>24 h.-30 days) - Blood transfusion - Operation need | – | 6% | Excluded | 1 | 7 |
Kouklakis G. | Greece | 2009 | Single center | 64 | 64 | Epinephrine group: 58.8 ± 11.2, Endoloop + clip group: 57.9 ± 9.7 | 35 | Epinephrine group: 2.7 ± 1.1 cm. Endoloop + clip group: 2.56 ± 1.2 cm. | Pedunculated | Ascending: 3 Transverse: 4 Descending:8 Sigmoid: 35 Rectum 14 | Epinephrine versus Endoloop and hemoclip | 0.01% (Total volume 2–5 ml) | Monopolar coagulation in endocut function (72 W) | -Early bleeding (within 24 h) -Late bleeding (>24 h.-30 days) - Blood transfusion | Neoplastic:5 Severe dysplasis: 13 Mild-moderate dysplasia:46 | 8% | Excluded | 3 | 8 |
Di Giorgio P. | Italy | 2004 | Single center | 488 | 488 | Epinephrine group: 63 ± 8.9, Controlled group: 62 ± 9.0, Snare group: 64 ± 9.2 | 267 | Epinephrine group: 24.72 ± 5.31 mm, Controlled group: 21.55 ± 4.77 mm, Snare group: 22.15 ± 5.92 mm. | Pedunculated | Right colon: 88 Left colon: 125 Rectosigmoid: 275 | Epinephrine versus Controlled versus Detachtable snare | 0.01% (Total volume 2 ml) | Bipolar cauterization, blended current (75 Watts) | -Early bleeding (within 24 h) -Late bleeding (>24 h.-30 days) | – | 4% | Excluded | – | 7 |